These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3689631)

  • 21. Development and implementation of simplified aminoglycoside empiric dosing guidelines.
    Reesor Nimmo C; Mamdani F; Baker A; Jewesson P
    Pharmacotherapy; 1993; 13(4):408-14. PubMed ID: 8361871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of a 3 mg/kg body weight loading dose of gentamicin or tobramycin in critically ill patients.
    Chelluri L; Warren J; Jastremski MS
    Chest; 1989 Jun; 95(6):1295-7. PubMed ID: 2721269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modification of Diet in Renal Disease and modified Cockcroft-Gault formulas in predicting aminoglycoside elimination.
    Bookstaver PB; Johnson JW; McCoy TP; Stewart D; Williamson JC
    Ann Pharmacother; 2008 Dec; 42(12):1758-65. PubMed ID: 19047358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring of serum aminoglycoside levels with once-daily dosing.
    Paterson DL; Robson JM; Wagener MM; Peters M
    Pathology; 1998 Aug; 30(3):289-94. PubMed ID: 9770195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a microcomputer program for predicting tobramycin serum concentrations.
    Abel SR; Aronoff GR
    Am J Hosp Pharm; 1984 Nov; 41(11):2397-9. PubMed ID: 6548872
    [No Abstract]   [Full Text] [Related]  

  • 26. Administration of tobramycin and gentamicin by the intravenous route every 6 hr in patients with normal renal function.
    Setia U; Gross PA
    J Infect Dis; 1976 Aug; 134 Suppl():S125-9. PubMed ID: 972270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Once-daily aminoglycoside dosing: impact on requests and costs for therapeutic drug monitoring.
    Nicolau DP; Wu AH; Finocchiaro S; Udeh E; Chow MS; Quintiliani R; Nightingale CH
    Ther Drug Monit; 1996 Jun; 18(3):263-6. PubMed ID: 8738765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of altered aminoglycoside volume of distribution on the adequacy of a three milligram per kilogram loading dose. Critical Care Research Group.
    Dorman T; Swoboda S; Zarfeshenfard F; Trentler B; Lipsett PA
    Surgery; 1998 Jul; 124(1):73-8. PubMed ID: 9663254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical assessment of a published model to predict aminoglycoside-induced nephrotoxicity.
    Garrison MW; Rotschafer JC
    Ther Drug Monit; 1989; 11(2):171-5. PubMed ID: 2718222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. More on variability in aminoglycoside volume of distribution.
    Dasta JF; Armstrong DK
    Clin Pharm; 1987 Mar; 6(3):193. PubMed ID: 3665376
    [No Abstract]   [Full Text] [Related]  

  • 31. Assessment of aminoglycoside dosing and estimated glomerular filtration rate in determining gentamicin and tobramycin area under the curve and clearance.
    Lim AK; Mathanasenarajah G; Larmour I
    Intern Med J; 2015 Mar; 45(3):319-29. PubMed ID: 25581282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aminoglycoside levels in critically ill surgical patients: the implications of physiologic criteria of sepsis.
    Cornwell EE; Belzberg H; Berne TV; Kern JW; Henriques G; Asensio JA; Demetriades D
    South Med J; 1997 Jan; 90(1):33-6. PubMed ID: 9003820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.
    Dager WE; King JH
    Ann Pharmacother; 2006 Jan; 40(1):9-14. PubMed ID: 16332944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variable pharmacokinetics of extended interval tobramycin or gentamicin among critically ill patients undergoing continuous venovenous hemofiltration.
    Chuk AC; Saeed F; Kousar N; Burrill S; Barns B; Rickrode G; Fu J; Katrych O; Saunders-Hao P; Block C; Lahey T
    Clin Nephrol; 2015 Oct; 84(4):214-21. PubMed ID: 26308080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of multiple courses of therapy on aminoglycoside clearance in adult patients with cystic fibrosis.
    Alghanem S; Paterson I; Touw DJ; Thomson AH
    J Antimicrob Chemother; 2013 Jun; 68(6):1338-47. PubMed ID: 23435691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in aminoglycoside volume of distribution in patients below ideal body weight.
    Tointon MM; Job ML; Peltier TT; Murphy JE; Ward ES
    Clin Pharm; 1987 Feb; 6(2):160-2. PubMed ID: 3665369
    [No Abstract]   [Full Text] [Related]  

  • 37. A microcomputer program for tobramycin consult services, based on the two-compartment pharmacokinetic model.
    Schentag JJ; Adelman MH
    Drug Intell Clin Pharm; 1983; 17(7-8):528-31. PubMed ID: 6688217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aminoglycoside pharmacokinetics on a microcomputer.
    Kaka JS; Buchanan EC
    Drug Intell Clin Pharm; 1983 Jan; 17(1):33-8. PubMed ID: 6687453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accuracy of serum gentamicin concentration predictions generated by a personal-computer software system.
    Robinson JD; Hatton RC; Russell WL; Klapp D; Lopez LM
    Clin Pharm; 1984; 3(5):509-16. PubMed ID: 6548429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of periocularly administered gentamicin on serum aminoglycoside concentrations.
    Van Lith RM; Appleby DH; Schwartz R; Sanders KL; Walker JP; Wing GL
    Clin Pharm; 1986 Mar; 5(3):231-3. PubMed ID: 3485502
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.